Kamil Ali-Jackson, Director of Rigel Pharmaceuticals RIGL, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $160.4K. The latest trade was on 06/22.

KA

KA

Kamil Ali-Jackson

Director

Company

Rigel Pharmaceuticals RIGL

First filing

23/07/17

Trades

13 trades

Buys / sales

0 / 2

12-month net buying

−$160.4K

Last trade

06/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Rigel PharmaceuticalsRIGL	Open-market sale10b5-1 plan	06/22	06/24	2,500 sh	$35.00	$87,500	−19.8%
Rigel PharmaceuticalsRIGL	Open-market sale10b5-1 plan	05/26	05/28	2,500 sh	$29.17	$72,925	−16.5%